Begnami MD - Search Results

1

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA. Silva EM, et al. Among authors: begnami md. Gastric Cancer. 2008;11(3):149-59. doi: 10.1007/s10120-008-0468-5. Epub 2008 Sep 30. Gastric Cancer. 2008. PMID: 18825309

2

Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa.

Meireles SI, Cristo EB, Carvalho AF, Hirata R Jr, Pelosof A, Gomes LI, Martins WK, Begnami MD, Zitron C, Montagnini AL, Soares FA, Neves EJ, Reis LF. Meireles SI, et al. Among authors: begnami md. Cancer Res. 2004 Feb 15;64(4):1255-65. doi: 10.1158/0008-5472.can-03-1850. Cancer Res. 2004. PMID: 14973074

3

Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication.

Begnami MD, Fregnani JH, Nonogaki S, Soares FA. Begnami MD, et al. Hum Pathol. 2010 Aug;41(8):1120-7. doi: 10.1016/j.humpath.2010.01.007. Epub 2010 Mar 23. Hum Pathol. 2010. PMID: 20334896

4

Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas.

Begnami MD, Montagnini AL, Vettore AL, Nonogaki S, Brait M, Simoes-Sato AY, Seixas AQ, Soares FA. Begnami MD, et al. World J Gastroenterol. 2006 Aug 21;12(31):4959-65. doi: 10.3748/wjg.v12.i31.4959. World J Gastroenterol. 2006. PMID: 16937490 Free PMC article.

5

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, da Costa WL Jr, Soares FA. Begnami MD, et al. J Clin Oncol. 2011 Aug 1;29(22):3030-6. doi: 10.1200/JCO.2010.33.6313. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709195

6

Identification of protein expression signatures in gastric carcinomas using clustering analysis.

Begnami MD, Fregnani JH, Brentani H, Torres C, Costa WL Jr, Montagnini A, Nonogaki S, Soares FA. Begnami MD, et al. J Gastroenterol Hepatol. 2012 Feb;27(2):378-84. doi: 10.1111/j.1440-1746.2011.06849.x. J Gastroenterol Hepatol. 2012. PMID: 21777278 Free article.

7

Prognostic factors in pelvic exenteration for gynecological malignancies.

Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, Begnami MD, Soares FA, Lopes A. Baiocchi G, et al. Among authors: begnami md. Eur J Surg Oncol. 2012 Oct;38(10):948-54. doi: 10.1016/j.ejso.2012.07.002. Epub 2012 Jul 18. Eur J Surg Oncol. 2012. PMID: 22818842

8

GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker.

Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. Carvalho KC, et al. Among authors: begnami md. Clinics (Sao Paulo). 2011;66(6):965-72. doi: 10.1590/s1807-59322011000600008. Clinics (Sao Paulo). 2011. PMID: 21808860 Free PMC article.

9

Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?

Martins MR, Santos RLD, Jatahy KDN, Matta MCD, Batista TP, Júnior JIC, Begnami MDFS, Torres LC. Martins MR, et al. J Surg Oncol. 2018 Apr;117(5):840-844. doi: 10.1002/jso.25001. Epub 2018 Mar 12. J Surg Oncol. 2018. PMID: 29529339

10

DNA Mismatch Repair-Deficient Colorectal Carcinoma: Referral Rate for Genetic Cancer Risk Assessment in a Brazilian Cancer Center.

Gomes AAD, Macedo MP, Torrezan GT, Zenun GR, Aguiar S Jr, Begnami MD, Carraro DM, Formiga MN. Gomes AAD, et al. Among authors: begnami md. J Gastrointest Cancer. 2021 Sep;52(3):997-1002. doi: 10.1007/s12029-020-00467-z. J Gastrointest Cancer. 2021. PMID: 32974876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page